» Articles » PMID: 10640959

A Clinicopathologic Study of Primary Small Intestine Lymphoma: Prognostic Significance of Mucosa-associated Lymphoid Tissue-derived Lymphoma

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2000 Jan 21
PMID 10640959
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It remains unclear whether the presence of mucosa-associated lymphoid tissue (MALT) lymphoma has prognostic implications for patients with primary small intestine lymphoma.

Methods: The clinicopathologic features of 80 patients with primary small intestine lymphoma were examined retrospectively in relation to the presence of MALT lymphoma. Survival was compared univariately and multivariately among the groups divided by clinicopathologic findings.

Results: Twenty-one cases (26%) were diagnosed as low grade B-cell lymphoma (15 marginal zone B-cell lymphoma of MALT type, 2 mantle cell lymphoma, and 4 follicle center lymphoma), 46 cases (58%) were diagnosed as high grade B-cell lymphoma (19 secondary large cell lymphoma with a low grade MALT component, 17 diffuse large cell lymphoma without MALT features, 7 Burkitt lymphoma, and 3 lymphoblastic lymphoma), and 13 cases (16%) were diagnosed as T-cell lymphoma. A significantly better survival was noted for patients without colorectal and/or gastric involvement, diffuse infiltration under macroscopy, high grade histology, and perforation. Those patients with MALT type tumors, less advanced stage of disease, B-cell phenotype, benign lymphoid follicular hyperplasia, and radical tumor resectability appeared to have a better survival rate. Based on Cox multivariate analysis, early stage disease and MALT-derived tumors were determined to be independent prognostic factors (P < 0.05).

Conclusions: The presence of MALT-derived lymphoma appears to have a favorable prognosis among patients with primary small intestinal lymphoma.

Citing Articles

Comparison of clinical features of patients with or without severe gastrointestinal complications in aggressive gastrointestinal lymphomas.

Liu X, Chen G, Cao D, Liu H, Ke X, Hu Y World J Gastrointest Oncol. 2024; 16(11):4409-4423.

PMID: 39554739 PMC: 11551637. DOI: 10.4251/wjgo.v16.i11.4409.


Efficacy and side effects of anti-CD19 CAR T-cell therapy in patients with relapsed/refractory gastrointestinal lymphoma.

Jiang Y, Mu J, Cui R, Li X, Wang J, Li Q Cancer Med. 2024; 13(4):e7064.

PMID: 38457256 PMC: 10923045. DOI: 10.1002/cam4.7064.


Ileocaecal Intussusception Due to Burkitt Lymphoma: A Surgical and Haematological Emergency.

Elkhawaga M, Ross B, Sugo E, Reedman-Hawes C, Balasuriya H Cureus. 2024; 15(12):e50904.

PMID: 38249231 PMC: 10799675. DOI: 10.7759/cureus.50904.


Endoscopic and Histopathological Characteristics of Gastrointestinal Lymphoma: A Multicentric Study.

Tran Q, Nguyen Duy T, Nguyen-Tran B, Nguyen-Thanh T, Ngo Q, Tran Thi N Diagnostics (Basel). 2023; 13(17).

PMID: 37685305 PMC: 10486743. DOI: 10.3390/diagnostics13172767.


Challenges in the diagnosis of marginal zone lymphoma with symptoms of small intestinal disease: a case report and scoping review of the literature.

Markopoulos K, Buhrer E, Banz Y, Dawson H, Engelbrecht S, Essig M J Gastrointest Oncol. 2022; 13(5):2583-2607.

PMID: 36388684 PMC: 9660065. DOI: 10.21037/jgo-22-74.